FDA approval of Opdivo + Yervoy for patients with hepatocellular carcinoma (HCC)
Bristol Myers Squibb Company today announced that Opdivo (nivolumab) 1 mg/kg plus Yervoy (ipilimumab) 3 mg/kg (injections for intravenous use) was approved by the U.S.
The Mesothelioma Center at Asbestos
Since 2006, the Mesothelioma Center has raised awareness for asbestos exposure & helped thousands of families find treatment & compensation.
Chan Zuckerberg Initiative Awards Fibrolamellar Cancer Foundation First Ever “Rare As One Network” Grant
The Chan Zuckerberg Initiative (CZI) announced that the Fibrolamellar Cancer Foundation (FCF) is among a select group of patient-led rare.
The Healing Power of Communication
Georgetown Lombardi Comprehensive Cancer Center was pleased and humbled by the overwhelming response to their inaugural Edward M. Kovach Cura Personalis Lecture held earlier this summer featuring Dr. John Marshall and America’s own Katie Couric where they discussed the the healing power of communication.
Cancer Caregiver Action Plan
The Cancer Caregiver Action Plan was developed based on conversations with fellow caregivers who asked for a way to ‘pay it forward’ — a way to help other caregivers by providing real world perspective and insight into the caregiver journey.
What You Need To Know About Gastric (Stomach) Cancer
Gastric (stomach) cancer is a disease in which malignant (cancer) cells form in the lining of the stomach. The stomach is in the upper abdomen and helps digest food.
Clinical Trials Highlight (Fall 2019)
Catch up on our investigator-initiated clinical trials. Ruesch Center faculty and their NIH collaborators are really making an effort to change the standard of care.
Time Counts: Embracing Carers Advocacy Toolkit
Time Counts is supporting individuals caring for a loved one by asking society to give time to connect with a caregiver.
Webinar: Setting course for the Alliance’s new strategic initiative to improve clinical trial participation
In this webinar, part five of our Transforming Trial Participation webinar series, we will discuss setting course for Alliance’s new strategic initiative to improve clinical trial participation.
Webinar: Where are the “sweet spots” for realistic improvement around GI cancers trial accrual
In this webinar, part four of our Transforming Trial Participation webinar series, we will discuss pushing the “lever:” Where are the “sweet spots” for realistic improvement around GI cancers trial accrual.